MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million ...

Kepler Capital analyst David Evans maintained a Buy rating on Merck KGaA (0O14 – Research Report) on November 1 and set a price target ...

added 4.64% or 1.37 points to end at 30.76 and Deutsche Telekom AG Na (ETR:DTEGn) was up 3.30% or 0.92 points to 28.77 in ...

Germany equities were higher at the close on Thursday, as gains in the Technology, Telecoms and Media sectors propelled ...

Report on how AI is driving market transformation - The global DNA sequencing market size is estimated to grow by USD 17.34 ...

The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

Global investors are eyeing fresh opportunities in China as the world second-largest economy accelerates its intelligent ...

Global investors are eyeing fresh opportunities in China as the world second-largest economy accelerates its intelligent green transformation With t ...

This eases the user's understanding of the market thoroughly, while also gaining knowledge about Anxiety Disorder Treatment market opportunities and the dominant players Pfizer Inc, Merck KGaA, Sanofi ...

Most recently, he served as Chief Operating Officer of Prometheus Biosciences, a biotechnology company focused on gastrointestinal diseases that was acquired by Merck for $10.8 billion ... News - a ...

Global investors are eyeing fresh opportunities in China as the world’s second-largest economy accelerates its intelligent, ...